← Open Payments lookup

KIMBERLY SCHIFF: Open Payments

NPI 1538630918 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$816 in 29 payments from 10 companies in 2025. Trend: 2023 $691 · 2024 $307 · 2025 $816

Food & beverage: $816
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation15$280
Incyte Corporation1$133
AstraZeneca Pharmaceuticals LP1$125
Daiichi Sankyo Inc.5$99
ABBVIE INC.2$46
Alnylam Pharmaceuticals Inc.1$38
Takeda Pharmaceuticals U.S.A., Inc.1$28
JAZZ PHARMACEUTICALS INC.1$27
GlaxoSmithKline, LLC.1$23
Celgene Corporation1$17

Products named: Fabhalta, Niktimvo, CALQUENCE, Vanflyta, VENCLEXTA, GIVLAARI, SCEMBLIX, ICLUSIG.

Industry payments across CA — which companies pay providers there.